Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhibition of Long Noncoding RNA Linc‐Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis

Hepatology(2020)10.1002/hep.31656Source: DataRank Database

Inhibition of Long Noncoding RNA Linc‐Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis is a research paper published in Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.97)OA: greenTopics (27)Linked Datasets (22)DataCite Reuse (22)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Subhayan Sur ORCID,Robert Steele ORCID,Ranjit Ray,Ratna B. Ray ORCID,Mousumi Khatun ORCID

Live enrichment

PubMed:33236406 PMC:PMC8141542 OpenAlex:https://openalex.org/W3109159825

NCI NIH HHS

Grant: P30 CA091842

NIGMS NIH HHS

Grant: P41 GM103422

National Institutes of Health

Grant: DK113645

NIDDK NIH HHS

Grant: R01 DK081817

NIDDK NIH HHS

Grant: R01 DK113645

NCATS NIH HHS

Grant: UL1 TR002345

National Institutes of Health

Grant: DK081817

FWCI

2.97

Citation Percentile

0.9%

Influential Citations

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: http://doi.wiley.com/10.1002/tdm_license_1.1

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8141542

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141542

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8141542

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31656

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep.31656

Fields of Study

Cancer-related molecular mechanisms researchHepatitis C virus researchRNA Research and SplicingBiologyMedicine

MeSH Terms

BiopsyCell LineHumansLiverDown-RegulationHepacivirusProtein Serine-Threonine KinasesDisease ProgressionHepatitis C, ChronicHepatocytesLipogenesisHost-Pathogen InteractionsRNA, Long Noncoding

Keywords

LipogenesisBiologyHepatitis C virusFatty acid synthaseCancer researchGeneVirusVirologyGenetics

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 10 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275735.v1figshare

Additional file 10 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275735figshare

Additional file 11 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275738.v1figshare

Additional file 11 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275738figshare

Additional file 6 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275756.v1figshare

Additional file 6 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275756figshare

Additional file 7 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275759.v1figshare

Additional file 7 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275759figshare

Additional file 8 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275762.v1figshare

Additional file 8 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275762figshare

Additional file 9 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275768.v1figshare

Additional file 9 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275768figshare

Additional file 4 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275750.v1figshare

Additional file 3 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275747figshare

Additional file 1 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275741.v1figshare

Additional file 4 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275750figshare

Additional file 1 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275741figshare

Additional file 2 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275744figshare

Additional file 5 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275753figshare

Additional file 5 of Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer

10.6084/m9.figshare.21275753.v1figshare